OrganOx Ltd, spun-out of the University of Oxford by Oxford University Innovation Ltd in 2008, has completed a Series B investment round of £2.75m. The round, which was over-subscribed, was supported by existing shareholders and a number of new ones, including the Royal Society.
Oxford Catalysts spun-out from the University of Oxford by Oxford University Innovation Ltd in 2006, has announced a further funding round to progress from operating as a research and development company to a commercial product company.
TissueFlex® addresses the missing link between conventional 2D assays and in vivo studies, providing a true three-dimensional (3D) platform for in vitro cultures with more in vivo-like behaviour to improve the predictivity of drug safety and efficacy testing.
Oxford Electromagnetic Acoustic Imaging (OxEMA) is a patented healthcare imaging technology offering superior diagnostic power to conventional ultrasound systems and MRI-like images.
Oxyntix Ltd, a new company spun-out from the Department of Engineering Science at the University of Oxford by Oxford University Innovation Ltd., has completed an investment round of £1m.
Isis welcomes the announcement from Oxford Photovoltaics Limited that it has completed a second funding round in 9 months.
Isis spin-out OXEMS will improve quality assurance, health and safety, and cost for the management of pipelines and other utilities.
A scanner which combines the convenience of a desktop scanner with the functionality of a powerful laboratory imaging device has been developed at the University of Oxford’s Classics Department, and is now being commercialised by a new company Oxford Multi Spectral Limited which was today spun out by the University’s technology transfer company Oxford University Innovation.
Scientific imaging will be given a boost by a new company spun out from the University of Oxford. Oxford Imaging Detectors, which is developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level, has been set up by the University’s technology transfer company Oxford University Innovation.
In a letter to Nature Biotechnology, Oxitec have reported that field populations of mosquitoes responsible for the spread of dengue may be suppressed by using a proprietary strain of mosquito.
